Navigation Links
SemBioSys announces 2007 third quarter results
Date:11/1/2007

123,039 and $390,570 for the corresponding periods in 2006. The difference in revenue relates primarily to the recognition of an upfront license fee payment received from Martek in the first quarter of 2007 as well as contract research revenue recognized in the first half of 2007 and three-month and nine-month periods ended September 30, 2006.

Total expenditures for the three-month and nine-month periods ended September 30, 2007 were $4,022,642 and $12,017,416 respectively, compared with $2,949,791 and $10,706,226 for the corresponding periods last year.

Research and development expenses for the three-month and nine-month periods ended September 30, 2007 were $1,892,224 and $5,560,941 respectively, compared with $1,360,045 and $3,843,207 for the corresponding periods last year. The difference is primarily from increased personnel and outsourcing related to preclinical costs and the related support costs in all areas of research and development with an expanded focus on insulin and Apo AI. As SemBioSys prepares to enter clinical trials, all lab related activities continue to substantially increase resulting in a higher overall cost. The Company has also expanded the plant growth team and infrastructure both indoors and in the field as its programs further progress.

General and administrative expenses for the three-month and nine-month periods ended September 30, 2007 were $1,041,949 and $3,152,426 respectively, compared with $903,753 and $2,695,669 for the corresponding periods last year. The difference is mainly due to newly added staff to support expanded operations and increased investor relations activities as the Company broadens its exposure to U.S. and European markets.

Intellectual property costs for the three-month and nine-month periods ended September 30, 2007 were $237,430 and $1,073,093 respectively, compared with $217,269 and $2,561,564 for the corresponding periods last year. This difference in the nine-month period is primarily
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ...
(Date:12/24/2014)... On Friday, December 19, 2014, President Obama signed ... Appropriations Act of 2015, which for the first time, ... the Congressionally Directed Medical Research Programs (CDMRP) administered by ... working in conjunction with its allies on Capitol Hill, ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... and SOUTH SAN FRANCISCO, Calif., June 23, The ... today announced Robyn Barst as the recipient of,the ... Arterial,Hypertension (PAH) Care. The grant, in the amount ... Dr. Barst,s choice in order to support,continued excellence ...
... Premier healthcare,alliance Purchasing Partners division recently announced ... one of 15 winners,chosen for the Pinnacle ... suppliers,representing the top two percent of healthcare ... exceeds the expectations of,Premier and its members ...
... Canadian Dairy Commission funds formulation of two beverages with GG-XT ... ... /PRNewswire-FirstCall/ - The Canadian Dairy Commission,has funded the formulation of ... Allegiance filed Canadian and International Patent Applications, and,Health Canada ...
Cached Biology Technology:Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 2Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 3Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 4Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance 2Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance 3Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 2Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 3
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... the "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... Apple introduced the fingerprint reading feature with the iPhone ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... cherries may be good for more than just making pie, ... University of Michigan Health System researchers and presented today at ... rats, the researchers report that animals that received powdered tart ... sugar, less fat storage in the liver, lower oxidative stress ...
... The heart is one of the most energy demanding ... function properly accounts for 600,000 deaths each year. Similarly, ... beloved as a sport- and food fish, requires dynamic ... swimming activity. , Previous studies of trout ...
... 2nd issue of the online, open-access journal PLoS ONE, shows ... Madagascar, there are also large areas of forests regenerating. The ... the study area, with an overall net increase of 4 ... highest level of plant endemism (species found only in a ...
Cached Biology News:A cherry on top: Tart cherries may alter heart/diabetes factors 2A cherry on top: Tart cherries may alter heart/diabetes factors 3A cherry on top: Tart cherries may alter heart/diabetes factors 4Hearts of male and female rainbow trout are different 2Hearts of male and female rainbow trout are different 3Madagascan tropical forests return thanks to better management and well-defined ownership 2
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... The Ph.D. Peptide Display Cloning System ... on the surface of bacteriophage M13 as ... between each displayed peptide and its encoding ... of targets can then be selected by ...
... of the yolk protein Vtg in plasma from ... sensitive biomarker for endocrine disrupting chemicals (EDCs) with ... become an accepted screening test for the estrogenic ... trout) EIA kit is a double-antibody immunometric (sandwich) ...
... synthetic peptide whose sequence corresponds to residues 115-133 of rat SAP97. ... V115 - L - P - S - E - ... - P - N - E - V - L - ... added to facilitate conjugation and is not a part of the ...
Biology Products: